Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Industrials | 10.61% |
| 5 | Consumer Staples | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
World Acceptance Corp
WRLD
$875M
| $828K | ﹤0.01% |
10,900
-34,800
| -76% | -$2.71M |
|
|
OB
2127
DELISTED
Onebeacon Insurance Group Ltd
OB
| $824K | ﹤0.01% |
53,000
-2,000
| -4% | -$30.8K |
|
2128
United Fire Group
UFCS
$1.37B
| $823K | ﹤0.01% |
+28,083
| New | +$802K |
|
|
YDKG
2129
Yueda Digital Holding
YDKG
$5.81M
| $822K | ﹤0.01% |
180
+3
| +2% | +$13K |
|
2130
Natural Alternatives International
NAII
$13.6M
| $822K | ﹤0.01% |
155,700
+2,800
| +2% | +$15.8K |
|
2131
Alamos Gold
AGI
$13.8B
| $819K | ﹤0.01% |
+81,000
| New | +$742K |
|
|
BSPM
2132
DELISTED
Biostar Pharmaceuticals, Inc.
BSPM
| $817K | ﹤0.01% |
80,524
+3,228
| +4% | +$35.7K |
|
|
TEF
2133
DELISTED
Telefonica
TEF
| $816K | ﹤0.01% |
64,838
| – | – |
|
|
THRD
2134
DELISTED
TF FINANCIAL CORP COM STK (PA)
THRD
| $814K | ﹤0.01% |
19,039
+3,600
| +23% | +$124K |
|
|
B
2135
DELISTED
Barnes Group Inc.
B
| $809K | ﹤0.01% |
+21,000
| New | +$801K |
|
2136
Regeneron Pharmaceuticals
REGN
$83B
| $808K | ﹤0.01% |
+2,862
| New | +$848K |
|
2137
SIGA Technologies
SIGA
$207M
| $807K | ﹤0.01% |
286,205
+141,005
| +97% | +$395K |
|
2138
Northrim BanCorp
NRIM
$599M
| $803K | ﹤0.01% |
125,600
-5,424
| -4% | -$33.4K |
|
|
BORN
2139
DELISTED
China New Borun Corporation
BORN
| $799K | ﹤0.01% |
290,500
-59,752
| -17% | -$164K |
|
|
ATE
2140
DELISTED
Advantest Corp
ATE
| $791K | ﹤0.01% |
64,000
-10,500
| -14% | -$120K |
|
2141
Lincoln Educational Services
LINC
$945M
| $790K | ﹤0.01% |
176,000
+15,151
| +9% | +$60K |
|
2142
Standard Motor Products
SMP
$877M
| $786K | ﹤0.01% |
17,595
-94,599
| -84% | -$3.82M |
|
|
MSON
2143
DELISTED
Misonix Inc
MSON
| $785K | ﹤0.01% |
116,100
+1,700
| +1% | +$10.7K |
|
|
CALL
2144
DELISTED
magicJack VocalTec Ltd
CALL
| $782K | ﹤0.01% |
51,700
-297,000
| -85% | -$5M |
|
2145
KNOT Offshore Partners
KNOP
$362M
| $779K | ﹤0.01% |
+27,510
| New | +$760K |
|
2146
Napco Security Technologies
NSSC
$1.37B
| $779K | ﹤0.01% |
286,814
-6,528
| -2% | -$19.3K |
|
|
WLH
2147
DELISTED
WILLIAM LYON HOMES
WLH
| $779K | ﹤0.01% |
25,600
-115,800
| -82% | -$3.11M |
|
2148
Traws Pharma
TRAW
$8.12M
| $778K | ﹤0.01% |
+3
| New | +$885K |
|
|
VRML
2149
DELISTED
Vermillion, Inc.
VRML
| $778K | ﹤0.01% |
301,500
+19,300
| +7% | +$55.3K |
|
2150
CDW
CDW
$17.8B
| $775K | ﹤0.01% |
24,300
-274,226
| -92% | -$8.05M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.